Wordt geladen...
Clinical outcome measures for Cutaneous Lupus Erythematosus
Cutaneous lupus erythematosus is a clinically heterogeneous group of rare skin diseases that only rarely have been subjected to controlled clinical trials. This may be have been partly due to a lack of suitable validated outcome instruments. Recently the FDA mandated that organ specific trials for l...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3081505/ https://ncbi.nlm.nih.gov/pubmed/20693208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0961203310370049 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|